高代谢c-IA期肺癌:肺叶切除生存优于亚肺叶切除
本研究纳入2004年4月至2023年3月间接受手术的c-IA期肺癌患者,筛选PET/CT最大标准化摄取值≥3.0者共723例,其中肺叶切除532例(73.6%)、亚肺叶切除191例(26.4%)。亚肺叶切除组5年总生存率和无病生存率均低于肺叶切除组(62.3% vs 79.9%和53.9% vs 70.3%),倾向性评分匹配后结果一致(60.7% vs 75.2%和51.6% vs 67.7%)。
要点
- c-IA期高代谢肺癌(SUVmax≥3.0)亚肺叶切除5年生存劣于肺叶切除。
- 匹配前5年总生存:亚肺叶切除62.3% vs 肺叶切除79.9%。
- 匹配后5年无病生存:亚肺叶切除51.6% vs 肺叶切除67.7%。
核心结论
- c-IA期高代谢肺癌且PET/CT最大标准化摄取值≥3.0的患者,亚肺叶切除后预后劣于肺叶切除。
研究设计与样本
- 评估接受F-18氟脱氧葡萄糖PET/CT及肺叶切除或亚肺叶切除的c-IA期肺癌患者,筛选最大标准化摄取值≥3.0者,采用倾向性评分匹配平衡组间特征。
主要发现
- 2004年4月至2023年3月共723例最大标准化摄取值≥3.0,肺叶切除532例(73.6%),亚肺叶切除191例(26.4%)。
- 5年总生存率亚肺叶切除62.3% vs 肺叶切除79.9%,5年无病生存率亚肺叶切除53.9% vs 肺叶切除70.3%。
- 倾向性评分匹配后5年总生存率亚肺叶切除60.7% vs 肺叶切除75.2%,5年无病生存率亚肺叶切除51.6% vs 肺叶切除67.7%。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The clinical trial showed that sublobar resection was not inferior to lobectomy in terms of disease-free survival in patients with peripherally located non-small-cell lung cancer ≤2 cm. However, it is not clear whether sublobar resection is indicated for all types of c-stage IA lung cancer. The purpose of this study was to clarify whether sublobar resection is indicated for c-stage IA hypermetabolic lung cancer. METHODS: Patients with c-stage IA lung cancer who underwent F-18 fluorodeoxyglucose positron emission tomography/computed tomography and lobectomy or sublobar resection were assessed. Of these, patients who had a maximum standardized uptake value ≥3.0 on positron emission tomography/computed tomography were evaluated. We compared survival rates after lobectomy versus sublobar resection. Propensity score matching was performed to balance patient characteristics between groups. RESULTS: Between April 2004 and March 2023, 723 patients underwent lobectomy or sublobar resection and had a maximum standardized uptake value ≥3.0 on positron emission tomography/computed tomography. Lobectomy and sublobar resection were performed in 532 (73.6%) and 191 (26.4%) patients, respectively. Both the 5-year overall and disease-free survival rates were worse after sublobar resection compared with lobectomy (62.3% vs 79.9% and 53.9% vs 70.3%, respectively). After propensity score matching, the 5-year overall and disease-free survival rates remained worse after sublobar resection compared with lobectomy (60.7% vs 75.2% and 51.6% vs 67.7%, respectively). CONCLUSIONS: Patients with c-stage IA hypermetabolic lung cancer with standardized uptake value ≥3.0 on positron emission tomography/computed tomography had a worse prognosis after sublobar resection than after lobectomy.
引用
- Shiono S, Endo M, Watanabe H, et al. Better survival with lobectomy versus sublobar resection in patients with hypermetabolic c-stage IA lung cancer on positron emission tomography/computed tomography. Eur J Cardiothorac Surg. 2024. PMID: 39321263. doi:10.1093/ejcts/ezae347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。